HRP20031026B1 - Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors - Google Patents

Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors

Info

Publication number
HRP20031026B1
HRP20031026B1 HRP20031026AA HRP20031026A HRP20031026B1 HR P20031026 B1 HRP20031026 B1 HR P20031026B1 HR P20031026A A HRP20031026A A HR P20031026AA HR P20031026 A HRP20031026 A HR P20031026A HR P20031026 B1 HRP20031026 B1 HR P20031026B1
Authority
HR
Croatia
Prior art keywords
het
alkyl
cycloalkyl
aryl
group
Prior art date
Application number
HRP20031026AA
Other languages
English (en)
Croatian (hr)
Inventor
Dominique@Louis@Nestor@Ghislai@Surleraux
Sandrine@Marie@Helene@Vendeville
Wim@Gaston@Verschueren
Marie@Pierre@T@M@M@G@De@Bethune
Herman@Augustinus@De@Kock
Abdellah@Tahri
Original Assignee
Tibotec@Pharmaceuticals@Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec@Pharmaceuticals@Ltd filed Critical Tibotec@Pharmaceuticals@Ltd
Publication of HRP20031026A2 publication Critical patent/HRP20031026A2/hr
Publication of HRP20031026B1 publication Critical patent/HRP20031026B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HRP20031026AA 2001-05-11 2003-12-10 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors HRP20031026B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201732 2001-05-11
PCT/EP2002/005212 WO2002092595A1 (en) 2001-05-11 2002-05-10 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors

Publications (2)

Publication Number Publication Date
HRP20031026A2 HRP20031026A2 (en) 2005-10-31
HRP20031026B1 true HRP20031026B1 (en) 2012-07-31

Family

ID=8180286

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20031026AA HRP20031026B1 (en) 2001-05-11 2003-12-10 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors

Country Status (32)

Country Link
US (2) US7622490B2 (hu)
EP (1) EP1387842B1 (hu)
JP (1) JP4467889B2 (hu)
KR (1) KR100878853B1 (hu)
CN (1) CN100549007C (hu)
AP (1) AP1652A (hu)
AR (1) AR035970A1 (hu)
AT (1) ATE429431T1 (hu)
AU (1) AU2002310818B2 (hu)
BG (1) BG66350B1 (hu)
BR (1) BR0209594A (hu)
CA (1) CA2444895C (hu)
CY (1) CY1109247T1 (hu)
CZ (1) CZ304524B6 (hu)
DE (1) DE60232067D1 (hu)
DK (1) DK1387842T3 (hu)
EA (1) EA009590B1 (hu)
EE (1) EE05307B1 (hu)
ES (1) ES2325809T3 (hu)
HK (1) HK1062912A1 (hu)
HR (1) HRP20031026B1 (hu)
HU (1) HUP0400438A3 (hu)
IL (1) IL158093A0 (hu)
MX (1) MXPA03010258A (hu)
NO (1) NO326883B1 (hu)
NZ (1) NZ529250A (hu)
OA (1) OA13134A (hu)
PL (1) PL209029B1 (hu)
PT (1) PT1387842E (hu)
SK (1) SK287952B6 (hu)
WO (1) WO2002092595A1 (hu)
ZA (1) ZA200307799B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359945C (en) 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
AU2003202914A1 (en) 2002-01-07 2003-07-24 Sequoia Pharmaceuticals Broad spectrum inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CA2537877C (en) * 2003-09-30 2015-03-17 Tibotec Pharmaceuticals Ltd. Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
US20050131042A1 (en) * 2003-12-11 2005-06-16 Flentge Charles A. HIV protease inhibiting compounds
US8193227B2 (en) 2003-12-11 2012-06-05 Abbott Laboratories HIV protease inhibiting compounds
RS51073B (sr) 2003-12-23 2010-10-31 Tibotec Pharmaceuticals Ltd. Proces za pripremanje (3r,3as,6ar)-heksahidrofuro│2,3-b│ furan-3-il (1s,2r)-3-││(4-aminofenil) sulfonil│(izobutil) amino │-1-benzil-2-hidroksipropilkarbamata
CA2549460C (en) 2003-12-23 2014-08-05 Tibotec Pharmaceuticals Ltd. Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
CN1997363B (zh) * 2004-05-07 2012-03-28 塞阔伊亚药品公司 抗耐药性反转录病毒蛋白酶抑制剂
MX2007010378A (es) 2005-02-25 2007-09-25 Tibotec Pharm Ltd Sintesis del precursor inhibidor de la proteasa.
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
US20120220520A1 (en) * 2006-10-17 2012-08-30 Van T Klooster Gerben Albert Eleutherius Bioavailable combinations for hcv treatment
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006030A1 (en) * 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
WO1996028464A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1996028418A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1996028463A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1997018205A1 (en) * 1995-11-15 1997-05-22 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204879D0 (sv) 1982-08-26 1982-08-26 Haessle Ab Novel chemical intermediates
DE69121436T2 (de) 1990-03-09 1997-01-09 Milliken Res Corp Organische Materialien, die sulfonamidogebundene Poly(oxyalkylen)gruppen tragen und ihre Herstellung
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE69311810T2 (de) * 1992-08-25 1997-11-27 Searle & Co N-(alkanoylamino-2-hydroxypropyl)-sulfonamide verwendbar als retrovirale proteaseninhibitoren
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
PT721331E (pt) 1993-10-01 2002-05-31 Astrazeneca Ab Processo i
EP1586558A3 (en) 1995-01-20 2005-10-26 G.D. Searle LLC. Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
RU2174519C2 (ru) 1995-03-10 2001-10-10 Джи. Ди. Сирл Энд Ко. Гидроксиэтиламино сульфонамиды гетероциклокарбонил аминокислоты, ингибирующие ретровирусную протеазу
DK0904060T3 (da) 1996-05-20 2004-04-13 Janssen Pharmaceutica Nv Antifungale præparater med forbedret biotilgængelighed
PT969821E (pt) 1997-03-26 2003-10-31 Janssen Pharmaceutica Nv Pastilhas tendo um nucleo revestido com um antifungico e um polimero
GB9717849D0 (en) 1997-08-23 1997-10-29 Seal Sands Chemicals Limited Preparation of pyridene derivatives
AU2012199A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
AU2010299A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
AP2000001856A0 (en) 1997-12-24 2000-09-30 Vertex Pharma Prodrugs of aspartyl protease inhibitors.
CA2336160C (en) 1998-06-23 2015-02-17 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of compounds for treating hiv
AU4828199A (en) 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
NZ528954A (en) * 2001-04-09 2005-04-29 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006030A1 (en) * 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
WO1996028464A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1996028418A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1996028463A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1997018205A1 (en) * 1995-11-15 1997-05-22 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors

Also Published As

Publication number Publication date
BG66350B1 (bg) 2013-08-30
CN1507446A (zh) 2004-06-23
NO326883B1 (no) 2009-03-09
US20100029632A1 (en) 2010-02-04
CA2444895C (en) 2011-02-15
EP1387842B1 (en) 2009-04-22
US20040106661A1 (en) 2004-06-03
ZA200307799B (en) 2005-03-30
EE200300547A (et) 2004-02-16
PT1387842E (pt) 2009-07-20
CN100549007C (zh) 2009-10-14
NZ529250A (en) 2005-05-27
IL158093A0 (en) 2004-03-28
HK1062912A1 (en) 2004-12-03
HRP20031026A2 (en) 2005-10-31
ATE429431T1 (de) 2009-05-15
DK1387842T3 (da) 2009-08-10
WO2002092595A1 (en) 2002-11-21
KR20040022417A (ko) 2004-03-12
NO20034988D0 (no) 2003-11-10
AP2003002904A0 (en) 2003-12-31
CZ304524B6 (cs) 2014-06-18
AU2002310818B2 (en) 2007-12-13
HUP0400438A3 (en) 2007-08-28
CY1109247T1 (el) 2014-07-02
SK287952B6 (sk) 2012-06-04
EP1387842A1 (en) 2004-02-11
OA13134A (en) 2006-12-13
US7863306B2 (en) 2011-01-04
CA2444895A1 (en) 2002-11-21
EA200301234A1 (ru) 2004-04-29
PL366780A1 (en) 2005-02-07
BG108309A (bg) 2004-12-30
JP4467889B2 (ja) 2010-05-26
SK14902003A3 (sk) 2004-07-07
EA009590B1 (ru) 2008-02-28
CZ20033290A3 (cs) 2004-05-12
MXPA03010258A (es) 2005-03-07
ES2325809T3 (es) 2009-09-18
EE05307B1 (et) 2010-06-15
US7622490B2 (en) 2009-11-24
BR0209594A (pt) 2004-03-30
KR100878853B1 (ko) 2009-01-15
JP2004534757A (ja) 2004-11-18
AR035970A1 (es) 2004-07-28
HUP0400438A2 (hu) 2004-08-30
DE60232067D1 (de) 2009-06-04
AP1652A (en) 2006-08-11
PL209029B1 (pl) 2011-07-29

Similar Documents

Publication Publication Date Title
HRP20031026B1 (en) Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
ES2543607T3 (es) Ciertas amidas sustituidas, método de obtención, y método de su uso
ES2618630T3 (es) Composiciones terapéuticas y métodos de uso relacionados
RS52099B (en) SUBSTITUTED BENZIMIDAZOLES AS KINASE INHIBITORS
CO5180537A1 (es) Nuevos derivados de hexa-, penta- y tetra-peptidos como inhibidores de la hepatitis c. comprendiendo sus racematos, diastereoisomeros e isomeros opticos y procedimiento para la preparacion de los mismos
AR045731A1 (es) Compuestos de aminotriazol utiles como inhibidores de quinasas de proteinas
AR016499A1 (es) Compuestos de pirrolo[2,3-d]pirimidina, composiciones y procesos para su uso en medicina.
CO6251257A2 (es) Derivados de guanina policiclicos y sus metodos de uso
HRP20010200B1 (en) 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
HRP20050895B1 (hr) Ftalazinon derivati
CO6190523A2 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
AR064731A1 (es) Derivados de 2,4-dianilinopirimidinas, su preparacion, composiciones farmaceuticas y usos como inhibidores de ikk
AR033793A1 (es) Compuestos derivados del benceno, su utilizacion, procedimientos para su preparacion y composiciones farmaceuticas que los contienen
PE20211779A1 (es) COMPUESTOS DE PIRAZOLO[3,4-b]PIRIDINA COMO INHIBIDORES DE CINASAS TAM Y MET
HRP20050606B1 (hr) Supstituirani oksindol sulfonamid hiv proteazni inhibitori širokog spektra
DE60209497D1 (de) Schmierölzusammensetzung enthaltend ein gemisch aus carboxylsäuren und aminen als rostschutzmittel
RS50491B (sr) Ciklopentanoindoli, smeše koje sadrže takva jedinjenja i metodi lečenja
AR044342A1 (es) Derivados de bencimidazol
AR087711A1 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y uso de los mismos para el tratamiento de trastornos neurodegenerativos
RS52934B (en) Pyridazine Derivatives As We Are Inhibitors
AR072428A1 (es) Derivados de pirimidin nucleotidos inhibidores de polimerasas del virus de la hepatitis c (vhc), composiciones farmaceuticas que los contienen y metodo para prepararlos.
AR066799A1 (es) Antagonistas para el receptor ccr2 y sus usos
CO5640084A2 (es) Ligandos de receptores cannabinoides y sus usos
AR034792A1 (es) Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, su preparacion y su aplicacion en terapeutica
AR070953A1 (es) Proceso para estabilizar monomeros con insaturaciones olefinicas y una composicion que contiene dicho monomero

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20150408

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20160510